Aggregate evidence quality: B
BenefitDiagnosis allows decisions regarding management to be made. Children likely to benefit from antimicrobial therapy will be identified.
HarmInappropriate diagnosis may lead to unnecessary treatment. A missed diagnosis may lead to persistent infection or complications
CostInappropriate diagnosis may lead to unnecessary cost of antibiotics. A missed diagnosis leads to cost of persistent illness (loss of time from school and work) or cost of caring for complications.
Benefits-harm assessmentPreponderance of benefit.
Value judgmentsNone.
Role of patient preferenceLimited.
Intentional vaguenessNone.
ExclusionsChildren aged <1 year or older than 18 years and with underlying conditions.